Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report

ABSTRACT CONTEXT: Recurrent respiratory papillomatosis (RRP) is the most common laryngeal tumor. During childhood, it may present in extremely severe forms defined by the need for frequent surgical procedures to relieve respiratory distress and/or involvement of extralaryngeal sites such as lung in...

Full description

Bibliographic Details
Main Authors: Rebecca Maunsell, Maria Angela Bellomo-Brandão
Format: Article
Language:English
Published: Associação Paulista de Medicina 2017-09-01
Series:São Paulo Medical Journal
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802017005012102&lng=en&tlng=en
_version_ 1818033173826633728
author Rebecca Maunsell
Maria Angela Bellomo-Brandão
author_facet Rebecca Maunsell
Maria Angela Bellomo-Brandão
author_sort Rebecca Maunsell
collection DOAJ
description ABSTRACT CONTEXT: Recurrent respiratory papillomatosis (RRP) is the most common laryngeal tumor. During childhood, it may present in extremely severe forms defined by the need for frequent surgical procedures to relieve respiratory distress and/or involvement of extralaryngeal sites such as lung involvement. Adjuvant therapies are indicated in these cases and interferon is one of the options. Pegylated interferon is more effective than conventional alpha interferon and, given its reported results in relation to treating hepatitis C over the past decade, we hypothesized that this might be more effective than conventional interferon also for treating respiratory papillomatosis. Use of a treatment strategy that eliminates the need for general anesthesia is particularly appealing, yet obtaining approval for use of medications that are not currently used for this purpose is challenging. CASE REPORT: We report the case of a child with severe RRP that had been followed for the preceding six years, who was treated with pegylated interferon after failure of other adjuvant therapies. There was noticeable improvement in the frequency of surgical procedures, which was regarded very receptively, considering the child’s history and previous response to other therapies. CONCLUSION: Pegylated interferon may be a good option for diminishing the need for surgical intervention in severe cases of recurrent respiratory papillomatosis.
first_indexed 2024-12-10T06:19:04Z
format Article
id doaj.art-c4d7e1b1a99b4ada9539f015e68e8389
institution Directory Open Access Journal
issn 1806-9460
language English
last_indexed 2024-12-10T06:19:04Z
publishDate 2017-09-01
publisher Associação Paulista de Medicina
record_format Article
series São Paulo Medical Journal
spelling doaj.art-c4d7e1b1a99b4ada9539f015e68e83892022-12-22T01:59:23ZengAssociação Paulista de MedicinaSão Paulo Medical Journal1806-94602017-09-01010.1590/1516-3180.2017.0031240317S1516-31802017005012102Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case reportRebecca MaunsellMaria Angela Bellomo-BrandãoABSTRACT CONTEXT: Recurrent respiratory papillomatosis (RRP) is the most common laryngeal tumor. During childhood, it may present in extremely severe forms defined by the need for frequent surgical procedures to relieve respiratory distress and/or involvement of extralaryngeal sites such as lung involvement. Adjuvant therapies are indicated in these cases and interferon is one of the options. Pegylated interferon is more effective than conventional alpha interferon and, given its reported results in relation to treating hepatitis C over the past decade, we hypothesized that this might be more effective than conventional interferon also for treating respiratory papillomatosis. Use of a treatment strategy that eliminates the need for general anesthesia is particularly appealing, yet obtaining approval for use of medications that are not currently used for this purpose is challenging. CASE REPORT: We report the case of a child with severe RRP that had been followed for the preceding six years, who was treated with pegylated interferon after failure of other adjuvant therapies. There was noticeable improvement in the frequency of surgical procedures, which was regarded very receptively, considering the child’s history and previous response to other therapies. CONCLUSION: Pegylated interferon may be a good option for diminishing the need for surgical intervention in severe cases of recurrent respiratory papillomatosis.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802017005012102&lng=en&tlng=enPapillomatosisRespiratoryPeginterferonChild
spellingShingle Rebecca Maunsell
Maria Angela Bellomo-Brandão
Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report
São Paulo Medical Journal
Papillomatosis
Respiratory
Peginterferon
Child
title Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report
title_full Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report
title_fullStr Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report
title_full_unstemmed Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report
title_short Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report
title_sort pegylated interferon for treating severe recurrent respiratory papillomatosis in a child case report
topic Papillomatosis
Respiratory
Peginterferon
Child
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802017005012102&lng=en&tlng=en
work_keys_str_mv AT rebeccamaunsell pegylatedinterferonfortreatingsevererecurrentrespiratorypapillomatosisinachildcasereport
AT mariaangelabellomobrandao pegylatedinterferonfortreatingsevererecurrentrespiratorypapillomatosisinachildcasereport